Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease
Jessica Nouws, Feng Wan, Eric Finnemore, Willy Roque, So-Jin Kim, Isabel Bazan, Chuan-xing Li, C. Magnus Skold, Qile Dai, Xiting Yan, Maurizio Chioccioli, Veronique Neumeister, Clemente J. Britto, Joann Sweasy, Ranjit Bindra, Åsa M. Wheelock, Jose L. Gomez, Naftali Kaminski, Patty J. Lee, Maor Sauler
Jessica Nouws, Feng Wan, Eric Finnemore, Willy Roque, So-Jin Kim, Isabel Bazan, Chuan-xing Li, C. Magnus Skold, Qile Dai, Xiting Yan, Maurizio Chioccioli, Veronique Neumeister, Clemente J. Britto, Joann Sweasy, Ranjit Bindra, Åsa M. Wheelock, Jose L. Gomez, Naftali Kaminski, Patty J. Lee, Maor Sauler
View: Text | PDF
Research Article Pulmonology

MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease

  • Text
  • PDF
Abstract

The pathogenesis of chronic obstructive pulmonary disease (COPD) involves aberrant responses to cellular stress caused by chronic cigarette smoke (CS) exposure. However, not all smokers develop COPD and the critical mechanisms that regulate cellular stress responses to increase COPD susceptibility are not understood. Because microRNAs are well-known regulators of cellular stress responses, we evaluated microRNA expression arrays performed on distal parenchymal lung tissue samples from 172 subjects with and without COPD. We identified miR-24-3p as the microRNA that best correlated with radiographic emphysema and validated this finding in multiple cohorts. In a CS exposure mouse model, inhibition of miR-24-3p increased susceptibility to apoptosis, including alveolar type II epithelial cell apoptosis, and emphysema severity. In lung epithelial cells, miR-24-3p suppressed apoptosis through the BH3-only protein BIM and suppressed homology-directed DNA repair and the DNA repair protein BRCA1. Finally, we found BIM and BRCA1 were increased in COPD lung tissue, and BIM and BRCA1 expression inversely correlated with miR-24-3p. We concluded that miR-24-3p, a regulator of the cellular response to DNA damage, is decreased in COPD, and decreased miR-24-3p increases susceptibility to emphysema through increased BIM and apoptosis.

Authors

Jessica Nouws, Feng Wan, Eric Finnemore, Willy Roque, So-Jin Kim, Isabel Bazan, Chuan-xing Li, C. Magnus Skold, Qile Dai, Xiting Yan, Maurizio Chioccioli, Veronique Neumeister, Clemente J. Britto, Joann Sweasy, Ranjit Bindra, Åsa M. Wheelock, Jose L. Gomez, Naftali Kaminski, Patty J. Lee, Maor Sauler

×

Figure 1

miR-24-3p is decreased in COPD and inversely correlates with disease severity.

Options: View larger image (or click on image) Download as PowerPoint
miR-24-3p is decreased in COPD and inversely correlates with disease sev...
(A) Coefficients of Spearman correlations (ρ) between microRNAs versus percent radiographic emphysema (y axis) (n = 121) and microRNAs versus FEV1 percent predicted (x axis) (n = 172) in the LGRC cohort. Blue indicates microRNAs correlated with FEV1 percent predicted (FDR < 0.05). Red indicates microRNAs correlated with percent radiographic emphysema and FEV1 percent predicted (FDR < 0.05). (B) Log2-transformed microarray expression of miR-24-3p in the discovery and validation LGRC cohorts. discovery cohort: n = 28 for No COPD, n = 36 for GOLD I & II, n = 20 for GOLD III & IV. validation cohort: n = 50 for No COPD, n = 14 for GOLD I & II, n = 24 for GOLD III & IV. (C) miR-24-3p expression (ΔCt miR-24-3p/RNU48) measured by RT-PCR in lung tissue samples from the confirmatory cohort. n = 28 for No COPD, n = 35 for GOLD I & II COPD, and n = 24 for GOLD III & IV COPD. (D) Heatmap of miR-24-3p expression (ΔCt miR-24-3p/RNU48) measured by RT-PCR in lung tissue samples from the confirmatory cohort versus FEV1 percent predicted (n = 87) and percent radiographic emphysema (n = 75). The regression coefficients and P values are adjusted for the effects of age, sex, and smoking status. Yellow denotes increase above the sample median, and purple denotes decrease below the sample median. (E) Log2-transformed microarray expression of miR-24-3p in airway brushings from the COSMIC cohort. n = 22 for never smokers, n = 10 for current smokers without COPD, n = 17 for current and former smokers with COPD (GOLD I), and n = 13 for current and former smokers with COPD (GOLD II). Error bars represent median ± interquartile range (B and C) or mean ± SEM (E). ***P ≤ 0.0001, *P < 0.05, Kruskal-Wallis 1-way ANOVA (B and C) or ordinary 1-way ANOVA (E), correcting for multiple comparisons using the 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts